Hitoshi Toyoda

1.1k citations
13 papers · 812 indexed · h-index 10
Topics
Glycosylation and Glycoproteins Research (7 papers)HER2/EGFR in Cancer Research (5 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
Partner nations
JapanUnited Kingdom

In The Last Decade

Hitoshi Toyoda

12 papers receiving 800 citations

Peers

Hitoshi Toyoda
Comparison fields: 5 of 71
  • Molecular Biology 432
  • Oncology 359
  • Radiology, Nuclear Medicine and Imaging 131
  • Surgery 99
  • Immunology 93
Replace Nancy J. Sipes with:
Nancy J. Sipes United States
Laurence Maggiorella France
Tahereh Kamalati United Kingdom
Fumihiko Matsuno Japan
J Bradley Australia
Fiona Zhong United States
Valentı́n Mendoza Mexico
Rui Min China
Laura Bald United States
Diane Horn United States
Hitoshi Toyoda relative to Nancy J. Sipes United States Nancy J. Sipes's profile →
Citations per field
00.5×10×14×
Nancy J. Sipes · 1×
Citations per year

Countries citing papers authored by Hitoshi Toyoda

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Toyoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Toyoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Toyoda more than expected).

Fields of papers citing papers by Hitoshi Toyoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Toyoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Toyoda. The network helps show where Hitoshi Toyoda may publish in the future.

Co-authorship network of co-authors of Hitoshi Toyoda

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Toyoda. A scholar is included among the top collaborators of Hitoshi Toyoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Toyoda. Hitoshi Toyoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 1
2 58
3 22
4 31
5 18
6 130
7 25
8 0
9 119
10 109
11 234
12 64
13 1

About Hitoshi Toyoda

Hitoshi Toyoda is a scholar working on Oncology, Rehabilitation and Molecular Biology, having authored 13 papers that have together received 812 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (359 citations), Immunology and Allergy (56 citations) and Molecular Biology (432 citations). Hitoshi Toyoda has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Toshi Komurasaki, Daisuke Uchida, Shigeo Morimoto, Kazunori Hanada, Toshiaki Isobe, Yasuko Takayama, Yasushi Hanakawa, Yuji Shirakata, Koji Hashimoto and Kenshi Yamasaki. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026